Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

787 evidence items · page 12 / 32

5.4 %In the real-world CANTAM study, vomiting occurred in 5.4% of patients treated with pyronaridine-artesunate (PA).

Malipaludismepublished 2024Malaria journaleurope_pmcdocument of 14 observationsDOI 10.1186/s12936-024-04885-3

57 health_districts57 out of 75 health districts in Mali were selected for Malaria Seasonal Chemoprevention (SMC) over the next 3–5 years.

Malipaludismeobserved next 3–5 yearsHAL · Unilimdocument of 95 observations

80 %The southern health districts account for 80% of malaria cases.

MalipaludismeHAL · Unilimdocument of 95 observations

0.33 odds_ratioCompared with the control, SP plus artesunate reduced the odds of P. falciparum infection with an odds ratio of 0.33.

Malipaludismepublished 2022The American journal of tropical medicine and hygieneeurope_pmcdocument of 6 observationsDOI 10.4269/ajtmh.21-1218

71.4 %71,4 % des participants infectés par P. malariae étaient asymptomatiques.

MalipaludismeHAL · Unilimdocument of 214 observations

59.33 %Plasmodium falciparum était l'espèce la plus prévalente lors du dépistage passif avec une prévalence de 59,33 %.

MalipaludismeHAL · Unilimdocument of 214 observations

P. falciparum était de loin l'espèce la plus dominante suivie de P. malariae, et P. ovale reste la troisième espèce quel que soit le type de dépistage.

MalipaludismeHAL · Unilimdocument of 214 observations

79.8 %83 out of 104 positive malaria rapid diagnostic tests (mRDTs) were confirmed Plasmodium falciparum positive via qPCR, corresponding to a confirmation rate of 79.8%.

Malipaludismepublished 2016The American journal of tropical medicine and hygieneeurope_pmcdocument of 2 observations

10.7 %In children who received RTS,S/AS01E vaccine in Burkina Faso and Mali, 10.7% showed a 10-fold increase in anti-CSP IgG antibody titres post-2019 as measured by GSK ELISA.

Burkina Faso · Malipaludismeobserved post-2019HAL · Unilimdocument of 105 observations

1.9 per_1000SMC was associated with a 1.9‰ reduction in malaria incidence in health districts with an adjusted coverage rate from 50.0% to 80.0%.

MalipaludismeHAL · Unilimdocument of 111 observations

24 %The clumping phenotype was observed in 24% of severe malaria isolates from Malian children.

Malipaludismepublished 2007The American journal of tropical medicine and hygieneeurope_pmcdocument of 3 observationsDOI 10.4269/ajtmh.2007.77.943

91.8 %The median annual seasonal malaria chemoprevention (SMC) coverage rate increased from 91.8% in 2017–2018 to 95.0% in 2021–2022.

Malipaludismeobserved 2017–2018HAL · Unilimdocument of 111 observations

400 childrenThe malaria vaccine candidate FMP2.1/AS02A was tested in a Phase 2 clinical trial in 400 Malian children randomized to 3 doses of the AMA1 vaccine candidate or control rabies vaccine on days 0, 30 and 60.

Malipaludismepublished 2016Vaccineeurope_pmcdocument of 2 observations

200 pf/microlThe cut-off value for pyrogenic threshold of Plasmodium falciparum parasitaemia was around 200 pf/microl during the dry season in Bandiagara district, Mali.

Malipaludismeobserved dry season of 1994published 2005Tropical medicine & international health : TM & IHeurope_pmcdocument of 4 observationsDOI 10.1111/j.1365-3156.2005.01418.x

Pre-treatment of red blood cells with neuraminidase, trypsin, and chymotrypsin caused a significant reduction in Plasmodium malariae invasion.

Malipaludismepublished 2025PLoS neglected tropical diseaseseurope_pmcdocument of 4 observations

10 health districtsIn 2021–2022, 10 health districts in the north and south of Mali did not receive seasonal malaria chemoprevention due to COVID-19-related shortages and insufficient resource mobilization by the Malian government.

Malipaludismeobserved 2021–2022HAL · Unilimdocument of 111 observations

5,400 parasites/μLLa parasitémie moyenne pour les infections à Plasmodium ovale chez les participants asymptomatiques était de 5 400 parasites/μL.

MalipaludismeHAL · Unilimdocument of 214 observations

6,311 casesFrom May 2024 to February 2025, 6,311 malaria cases were confirmed in the Kidal region.

Malipaludismeobserved May 2024 to February 2025HAL · Unilimdocument of 80 observations

1 %Allele frequencies of K13-propeller mutations in sub-Saharan Africa ranged between 1% and 3%.

Malipaludismepublished 2015The Journal of infectious diseaseseurope_pmcdocument of 4 observations

60 %En 2018, seulement 60 % des cas de paludisme avaient été confirmés par microscopie optique au Mali.

Malipaludismeobserved 2018HAL · Unilimdocument of 214 observations

74.5 %After 3 years of seasonal malaria chemoprevention (SMC), the frequency of Pfdhps 437G mutation in Plasmodium falciparum was 74.5% compared to 64.6% at baseline in Ouelessebougou, Mali.

Malipaludismeobserved 2014-2016published 2022Malaria journaleurope_pmcdocument of 7 observationsDOI 10.1186/s12936-022-04059-z

1,380 parasites/microlitreLa médiane du nombre de parasites de Plasmodium ovale par microlitre chez les 95 patients du groupe Kollé est de 1 380 (IQR : 1 020–1 740).

MalipaludismeHAL · Unilimdocument of 62 observations

65.2 %Le taux de prévalence du paludisme chez les personnes malades était de 65,2 % dans la localité étudiée.

MalipaludismeHAL · Unilimdocument of 214 observations

84 %About 84% of the population lived in high and moderate malaria transmission strata.

MalipaludismeHAL · Unilimdocument of 95 observations

43.1 %On day 28, the rate of recurrent parasitemia in the Artemether-lumefantrine (AL) arm was 43.1% in patients with normal neutrophil levels.

Malipaludismeobserved day 28published 2023Journal of infection in developing countrieseurope_pmcdocument of 4 observationsDOI 10.3855/jidc.17089

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.